article thumbnail

Cell and gene therapies: why advanced medicines call for specialised logistics

Pharmaceutical Technology

For many decades, investigators have been working on innovative therapeutic modalities known as cell and gene therapies, which use modified versions of the body’s own cellular and genetic material to treat and potentially cure these diseases. A new frontier in cancer research.

article thumbnail

10 Key Learnings from Successful Cellular and Gene Therapy Trials for Rare Diseases

XTalks

Awareness of rare diseases is growing, and with a better understanding of the pathophysiology of many rare diseases, innovative treatment options are emerging, like gene therapies that can treat the root cause of rare genetic diseases and potentially provide long-term symptom relief, or even a definitive cure.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cell & Gene Therapy Product Development: How Can You Build a Successful Partnership with Your CRO’s Project Manager?

XTalks

Over the past few years, there has been a significant expansion in the cell and gene therapy landscape, with an increasing number of therapies entering clinical trials and receiving regulatory approvals. “I think if we all go into these relationships with this mindset, we’ll achieve great things together.”

article thumbnail

Innovate UK grant to support development of powdered gene therapy

Drug Discovery World

The funding will support the development of the company’s gene therapy in a powder, a non-viral gene delivery system to improve tissue regeneration following surgery. The post Innovate UK grant to support development of powdered gene therapy appeared first on Drug Discovery World (DDW).

article thumbnail

AscellaHealth Highlights 2022 Key Trends in Specialty Pharmacy: Rising Costs, Expensive Cell/Gene Therapies, Management of Patients on High-Cost Therapies & Vertical Integration of Specialty Pharmacies into Healthcare Organizations

BioTech 365

AscellaHealth Highlights 2022 Key Trends in Specialty Pharmacy: Rising Costs, Expensive Cell/Gene Therapies, Management of Patients on High-Cost Therapies & Vertical Integration of Specialty Pharmacies into Healthcare Organizations AscellaHealth Highlights 2022 Key Trends in Specialty Pharmacy: Rising Costs, Expensive Cell/Gene … Continue (..)

article thumbnail

STAT+: Pharmalittle: FDA approves a gene therapy for a rare blood disorder; pharmacy chains ordered to pay $650 million over opioid crisis

STAT News

The therapy, Zynteglo, is just the third gene therapy approved by the FDA, and the first to target a chronic blood disease. It uses an engineered virus to deliver a gene fix into the bone marrow of patients. Zynteglo will cost $2.8 million per patient, making it one of the most expensive medicines ever sold in the U.S.

article thumbnail

New UK intracellular drug delivery centre to support RNA development

Pharmaceutical Technology

Strathclyde Institute of Pharmacy and Biomedical Sciences head professor Yvonne Perrie said: “This centre will provide new capabilities for mRNA-based drug development and manufacture of cost-effective vaccines and therapeutics in the UK, boosting not only economic growth but also security of supply.”